Ruth Adams
Directeur Technique/Scientifique/R&D chez NUVALENT, INC.
Postes actifs de Ruth Adams
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| NUVALENT, INC. | Directeur Technique/Scientifique/R&D | 01/11/2020 | - |
Historique de carrière de Ruth Adams
Anciens postes connus de Ruth Adams
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
Vigeo Therapeutics, Inc.
 Vigeo Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Vigeo Therapeutics, Inc. manufactures cancer drugs. It develops therapies designed to reprogram the tumor immune microenvironment by targeting CD36 and CD47 via Tsp-1 induction. The company was founded by Randolph Watnick and Jing Watnick in 2011 and is headquartered in Cambridge, MA. | Directeur Technique/Scientifique/R&D | - | - |
Formation de Ruth Adams
| The University of Southampton | Undergraduate Degree |
Statistiques
Internationale
| Etats-Unis | 3 |
| Royaume-Uni | 2 |
Opérationnelle
| Chief Tech/Sci/R&D Officer | 2 |
| Undergraduate Degree | 1 |
Sectorielle
| Health Technology | 3 |
| Consumer Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| NUVALENT, INC. | Health Technology |
| Entreprise privées | 1 |
|---|---|
Vigeo Therapeutics, Inc.
Vigeo Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Vigeo Therapeutics, Inc. manufactures cancer drugs. It develops therapies designed to reprogram the tumor immune microenvironment by targeting CD36 and CD47 via Tsp-1 induction. The company was founded by Randolph Watnick and Jing Watnick in 2011 and is headquartered in Cambridge, MA. | Health Technology |
- Bourse
- Insiders
- Ruth Adams
- Expérience
